ADVERTISEMENT

survival benefit

Research in Review

Statin Therapy May Improve Survival in Patients with Metastatic SCLC

01/14/2016

JCP Editors

In a retrospective study published in PLoS ONE, researchers found a survival benefit associated with statin use in patients with small cell lung cancer (SCLC) that has spread to other regions of the body. SCLC,...

In a retrospective study published in PLoS ONE, researchers found a survival benefit associated with statin use in patients with small cell lung cancer (SCLC) that has spread to other regions of the body. SCLC,...

In a...

01/14/2016

Journal of Clinical Pathways

Cabozantinib Bests Everolimus for Treatment of Advanced Renal Cell Carcinoma

01/12/2016

JCP Editors

Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...

Cabozantinib improves progression-free survival in patients with advanced renal cell carcinoma, according to an ongoing clinical trial comparing the drug with everolimus, an immunosuppressant that is the current...

...

01/12/2016

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

October 26 ⁠–⁠ October 27

October 29 ⁠–⁠ November 2

See Full Calendar

Advertisement

Advertisement